Regulatory approval
Published by the Health Products Regulatory Authority.
The Republic of Ireland's Health Products Regulatory Authority (HPRA) has authorized anastrozole for the treatment of patients who are postmenopausal women with hormone receptor-positive advanced breast cancer.
This is written in the approval document as:
Treatment of hormone receptor-positive advanced breast cancer in postmenopausal women.
Citation
Therapeutic response
Precision oncology relationships for therapeutic response derived from this regulatory approval.
| Type | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| Sensitivity (+) | ER positive | Invasive Breast Carcinoma | Anastrozole | |
| Sensitivity (+) | PR positive | Invasive Breast Carcinoma | Anastrozole | |
| Sensitivity (+) | ER positive, PR positive | Invasive Breast Carcinoma | Anastrozole |